Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,704
Closed -$466K 12
2017
Q2
$466K Sell
2,704
-207
-7% -$33.7K 0.18% 181
2017
Q1
$478K Sell
2,911
-382
-12% -$63.5K 0.16% 216
2016
Q4
$481K Buy
3,293
+1,024
+45% +$154K 0.13% 251
2016
Q3
$378K Sell
2,269
-134
-6% -$22.7K 0.09% 361
2016
Q2
$366K Buy
+2,403
New +$374K 0.07% 508

Other funds holding AMGN

TFS Capital's AMGN Position: Q3 2017 in Review

TFS Capital sold out of Amgen (AMGN) in Q3 2017, closing a stake of 2,704 shares — an estimated $466K sold.

TFS Capital first reported a position in AMGN in Q2 2016 and held it in 5 quarters. The position peaked at $481K in Q4 2016. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • TFS Capital reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 2,704 Amgen shares in Q3 2017, an estimated $466K.
  • TFS Capital first reported a position in Amgen in Q2 2016 and held it in 5 quarters.
  • TFS Capital's Amgen position peaked at $481K in Q4 2016.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.